Top compounds associated with response to TDP1


Feature Type Standardized
Nominal ANOVA
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.013 0.7
mRNA Tipifarnib GDSC1000 pan-cancer AAC 0.014 0.7
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Rapamycin gCSI pan-cancer AAC 0.021 0.7
mRNA 5-FU CTRPv2 pan-cancer AAC 0.013 0.7
mRNA erismodegib CTRPv2 pan-cancer AAC -0.014 0.7
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.012 0.7
mRNA NVP-BEZ235 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Roscovitine GDSC1000 pan-cancer AAC -0.02 0.7
mRNA lovastatin CTRPv2 pan-cancer AAC 0.014 0.7
Download CSV